We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

QQQX:NASDAQNuveen NASDAQ 100 Dynamic Overwrite Fund Analysis

Data as of 2026-08-26 - not real-time

$30.48

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Nuveen Nasdaq 100 Dynamic Overwrite Fund is priced at $30.48 and its moving averages line up in bullish order, the shorter sitting above the longer. With RSI at 52.4 the momentum picture is neutral, alongside a bearish MACD signal. The recent range runs from support at $28.72 up to resistance at $31.35.
On a 1-10 scale the risk profile lands at 5 — moderate. With 30-day volatility of 17.2%, a beta of 1.04 and a maximum drawdown of 11.1%, position sizing matters here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
The horizons diverge: buy near-term but hold on a long view, at 3/10 conviction over the longer horizon.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 5/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 28.93
  • MACD momentum is negative

Medium Term

1–3 years
Neutral
Model confidence: 4/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 28.93
  • MACD momentum is negative

Long Term

> 3 years
Neutral
Model confidence: 3/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • 30-day volatility of 17.2%
  • Beta of 1.04 versus the benchmark

Key Metrics & Analysis

Closed-End Fund Metrics

Market Price30.48
Discount/Premium0.00%
Discount TrendStable

Technical Analysis

TrendBullish
RSI52.4
Support$28.72
Resistance$31.35
MA 20$30.37
MA 50$30.05
MA 200$28.93
MACDBearish
VolumeStable
Fear & Greed Index93.5

Risk Assessment

Beta1.04
Volatility17.16%
Sector RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.